Vascular Vision Pharmaceuticals is an independent R&D company established in 1997 to conduct pre-clinical evaluation for drug development and transitioning to industrial manufacture. Today, VVP has evolved into a cutting edge research and development company focused on advancing novel therapeutics in the areas of cardiovascular disease, ophthalmological disorders and oncology. VVP is committed to the development of technologies and services that bridge the critical gap in translational science between bench-side discoveries in the lab and clinical testing in the clinic. At VVP, we ARE translational science.